Back to the Top 100
Viz.ai logo

Rank 10AI & Clinical Intelligence

Viz.ai

Uses artificial intelligence to analyze medical imaging and coordinate real-time care pathways for stroke, vascular, and cardiac conditions.

Visit website
Signal Score
92.7
Total raised
$250M
Stage
Series D+
Founded
2016
Headquarters
San Francisco, United States
Region
North America

Their signal

Viz.ai pioneered FDA-cleared triage workflows, dramatically reducing treatment times across hundreds of hospital networks with proven clinical outcomes.

Signal Score 92.7editorial estimate, see how it is built
Capital (25% weight)94

Total raised, quality of investors and recency of the last round.

Growth (25% weight)92

Revenue trajectory, customer count, hiring and market pull.

Clinical & regulatory (20% weight)95

Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.

Team (15% weight)91

Founder track record, clinical depth on the bench and technical leadership.

Online visibility (15% weight)90

Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.

Also in AI & Clinical Intelligence

Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.